About

Founded in 2009, Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. Thermalin’s insulin designs are based on 25 years of insulin research by Dr. Michael Weiss, Chairman of the Biochemistry Department at Case Western Reserve University Medical School.